| Cat. No. |
Product Name |
Information |
| PC-72212 |
TT-OAD2
GLP-1 agonist
|
TT-OAD2 is a potent, selective, non-peptide agonist of glucagon-like peptide-1 (GLP-1) receptor with EC50 of 5 nM. |
| PC-72211 |
LY3502970
GLP-1 agonist
|
LY3502970 (Orforglipron, OWL-833) is a potent, selective, orally active non-peptide agonist of glucagon-like peptide-1 (GLP-1) receptor. |
| PC-72210 |
Danuglipron
GLP-1R agonist
|
Danuglipron (PF-06882961) is a potent, selective, non-peptide and orally bioavailable agonist of glucagon-like peptide-1 receptor (GLP-1R) with cAMP production EC50 of 1.1 nM. |
| PC-35834 |
NLY01
GLP-1R agonist
|
Pegsebrenatide (NLY01) is a potent, brain-penetrant long-acting GLP1R agonist. |
| PC-43539 |
Exenatide acetate
GLP-1 agonist
|
Exenatide acetate (Exendin-4 acetate) is the acetate of Exenatide, which is highly potent, long-acting glucagon-like peptide-1 receptor (GLP-1) agonist with IC50 of 3.22 nM. |
| PC-43538 |
Exenatide
GLP-1 agonist
|
Exenatide (Exendin-4) is a 39-aa peptide, highly potent, long-acting glucagon-like peptide-1 receptor (GLP-1) agonist with IC50 of 3.22 nM. |
| PC-43093 |
LGD-6972
GCGR antagonist
|
LGD-6972 (RVT 1502) is a novel potent, selective, orally bioavailable glucagon receptor (GCGR) antagonist. |
| PC-61363 |
Apraglutide
GLP-2 analog
|
A peptidic glucagon like peptide 2 (GLP-2) analogue for treatment of type2 diabetes.. |
| PC-70259 |
GLP-1 agonist 1
GLP1 agonist
|
GLP-1 agonist 1 is a potent, selective GLP-1 receptor agonist with EC50 of 1.4 uM in cAMP functional assays. |
| PC-70258 |
GLP-1 agonist 2
GLP-1 agonist
|
GLP-1 agonist 2 potent, selective GLP-1 receptor agonist with EC50 of 101 nM. |
| PC-70055 |
MK-3577
GCGR antagonist
|
MK-3577 is a potent, oral active glucagon receptor antagonist blocking the glucagon effect for the treatment of T2DM. |
| PC-70024 |
PF-06372222
Glucagon receptor NAM
|
PF-06372222 is a potent glucagon receptor (GCGR) negative allosteric modulator. |
